Sidney Farber

Deep Bio Announces Research Collaboration with a Major Cancer Institute

Retrieved on: 
Friday, July 23, 2021
Cancer, Medicine, Dana–Farber Cancer Institute, Harvard Medical School, Clinical medicine, NCI-designated Cancer Center, Prostate cancer, Sidney Farber, Giovanni Parmigiani

SEOUL, South Korea, July 23, 2021 /PRNewswire-PRWeb/ --Deep Bio, a leading company in digital pathology and cancer diagnostics, today announced a renewal of their Research Collaboration Agreement with Dana-Farber Cancer Institute aimed at evaluating prostate cancer tumors.

Key Points: 
  • SEOUL, South Korea, July 23, 2021 /PRNewswire-PRWeb/ --Deep Bio, a leading company in digital pathology and cancer diagnostics, today announced a renewal of their Research Collaboration Agreement with Dana-Farber Cancer Institute aimed at evaluating prostate cancer tumors.
  • Dana-Farber is a principal teaching affiliate of Harvard Medical School and the founding member of DanaFarber/Harvard Cancer Center, the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation.
  • This research project will investigate if Deep Bio's deep learning algorithm, DeepDx Prostate, can serve as an adjunct to pathologist diagnosis of pathology specimens.
  • "We are honored to contribute to the meaningful research at Dana-Farber Cancer Institute, a leading cancer treatment and research center," said Sun Woo Kim, the CEO and founder of Deep Bio.

AccessHope and Dana-Farber Cancer Institute Announce Foundational Partnership, Extending Access to Cancer Expertise Across the United States

Retrieved on: 
Tuesday, June 29, 2021
Research, Hospitals, Practice Management, Other Health, Managed care, Health, Other Science, Science, Oncology, Harvard Medical School, Medicine, Dana–Farber Cancer Institute, Health care, Health, Farber, Cancer, Sidney Farber, National Comprehensive Cancer Network, AccessHope, Dana-Farber Cancer Institute, ACCESSHOPE, DANA-FARBER CANCER INSTITUTE

AccessHope, LLC , a company that provides cancer expertise to employers and their health care partners, today announced a new foundational partnership with Dana-Farber Cancer Institute, extending member access to specialized cancer expertise to more people living with complex cancers across the United States.

Key Points: 
  • AccessHope, LLC , a company that provides cancer expertise to employers and their health care partners, today announced a new foundational partnership with Dana-Farber Cancer Institute, extending member access to specialized cancer expertise to more people living with complex cancers across the United States.
  • Through an employer benefit, employees of AccessHope clients have access to AccessHopes network of oncology experts.
  • Dana-Farber Cancer Institute blends leading science and exceptional care into transformative medicine and is a principal teaching affiliate of Harvard Medical School.
  • We provide the latest in cancer care for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center .

New Research Explores Immuno-oncology Effectiveness for Lung Cancer in Medicare Population

Retrieved on: 
Friday, May 21, 2021
Dana–Farber Cancer Institute, Harvard Medical School, Branches of biology, Comorbidity, Health, Biomarker, Cancer research, Medicine, Cancer, Sidney Farber

He noted that "the shorter survival times observed in the Medicare population may reflect the treatment of older patients with higher burdens of frailty and comorbidity.

Key Points: 
  • He noted that "the shorter survival times observed in the Medicare population may reflect the treatment of older patients with higher burdens of frailty and comorbidity.
  • We hope this research encourages additional conversations about the importance of biomarkers and markers of comorbidity in the evolution of personalized care for patients with lung cancer.
  • "\nDana-Farber Cancer Institute is one of the world\'s leading centers of cancer research and treatment.
  • We provide the latest treatmentsin cancer for adults through Dana-Farber/Brigham and Women\'s Cancer Center and for children through Dana-Farber/Boston Children\'s Cancer and Blood Disorders Center .

OOFOS Donates $1 Million to Dana-Farber Cancer Institute and the Jimmy Fund Reaching Milestone Moment

Retrieved on: 
Tuesday, January 26, 2021
Cancer organizations, Medicine, Dana–Farber Cancer Institute, Harvard Medical School, The Jimmy Fund, Farber, Health, Cancer research, Dàna, Sidney Farber, Pan-Mass Challenge

BRAINTREE, Mass., Jan. 26, 2021 /PRNewswire/ --OOFOS, the global leader in recovery footwear, announced today that its Project Pink initiative has reached a milestone moment, raising more than $1 Million for breast cancer research at Dana-Farber Cancer Institute.

Key Points: 
  • BRAINTREE, Mass., Jan. 26, 2021 /PRNewswire/ --OOFOS, the global leader in recovery footwear, announced today that its Project Pink initiative has reached a milestone moment, raising more than $1 Million for breast cancer research at Dana-Farber Cancer Institute.
  • The donation comes as a result of the company's years-long partnership and commitment to Dana-Farber and the Jimmy Fund.
  • OOFOS' Project Pink initiative is a program focused on giving back throughout the year by donating 2% of all sales made on OOFOS.com to Dana-Farber and the Jimmy Fund for breast cancer research.
  • For more information, go to www.oofos.com
    Dana-Farber Cancer Institute is one of the world's leading centers of cancer research and treatment.

Despite COVID-19 Pandemic, Pan-Mass Challenge Donates $50 Million Gift to Dana-Farber Cancer Institute and the Jimmy Fund

Retrieved on: 
Monday, December 7, 2020
Harvard Medical School, Dana–Farber Cancer Institute, Medicine, Health care, Medical specialties, Pan-Mass Challenge, The Jimmy Fund, Farber, Dàna, Trauma centers, Sidney Farber, Hope & Heroes Children's Cancer Fund

BOSTON, Dec. 7, 2020 /PRNewswire/ -- Dana-Farber Cancer Institute , a world leader in adult and pediatric cancer treatment and research, today received a generous $50 million gift from the Pan-Mass Challenge (PMC).

Key Points: 
  • BOSTON, Dec. 7, 2020 /PRNewswire/ -- Dana-Farber Cancer Institute , a world leader in adult and pediatric cancer treatment and research, today received a generous $50 million gift from the Pan-Mass Challenge (PMC).
  • One hundred percent of this meaningful gift will support the lifesaving mission of Dana-Farber and the Jimmy Fund, including immediate patient care needs, breakthrough discoveries and COVID-19-related cancer research.
  • Dana-Farber Cancer Institute is one of the world's leading centers of cancer research and treatment.
  • The PMC has since raised $767 million for adult and pediatric patient care and cancer research at Dana-Farber Cancer Institute through the Jimmy Fund.

Dana-Farber Cancer Institute Provides State-of-the-Art Oncology Support Services to Kronos Employees Through New Company Benefit

Retrieved on: 
Tuesday, February 11, 2020
Managed care, Hospitals, Health, Oncology, Harvard Medical School, Dana–Farber Cancer Institute, Farber, Health, Medicine, Sidney Farber

Dana-Farber Cancer Institute and Kronos Incorporated have joined forces to provide dedicated oncology care navigation services via a new benefit for Kronos employees and their beneficiaries.

Key Points: 
  • Dana-Farber Cancer Institute and Kronos Incorporated have joined forces to provide dedicated oncology care navigation services via a new benefit for Kronos employees and their beneficiaries.
  • Through this innovative program, Dana-Farber Direct Connect provides companies with dedicated support services for their employees and is proud to align with an organization like Kronos known for a culture steeped in caring for its employees, their families, and the communities where Kronos employees live and work.
  • Dana-Farber Cancer Institute is one of the worlds leading centers of cancer research and treatment.
  • We provide the latest in cancer for adults through Dana-Farber/Brigham and Women's Cancer Care and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center .

Dana-Farber Cancer Institute Receives Largest Gift Ever, a Record-Breaking $63 Million

Retrieved on: 
Monday, October 21, 2019
Cancer organizations, Harvard Medical School, Health, Dana–Farber Cancer Institute, The Jimmy Fund, Farber, Sidney Farber

BOSTON, Oct. 21, 2019 /PRNewswire/ -- Dana-Farber Cancer Institute , a world leader in adult and pediatric cancer treatment and research, today received its largest financial gift ever, $63 million, from the Pan-Mass Challenge (PMC).

Key Points: 
  • BOSTON, Oct. 21, 2019 /PRNewswire/ -- Dana-Farber Cancer Institute , a world leader in adult and pediatric cancer treatment and research, today received its largest financial gift ever, $63 million, from the Pan-Mass Challenge (PMC).
  • Since 1980, the PMC has raised more than $717 million for Dana-Farber, making an exceptional impact on life-saving cancer research and patient care at the institute.
  • "Raising $63 million in one year is an incredible feat, and this record-breaking gift will make an immense impact on our work in the fight against cancer."
  • The PMC has since raised $717 million for adult and pediatric patient care and cancer research at Dana-Farber Cancer Institute through the Jimmy Fund.

Dana-Farber Cancer Institute and the Jimmy Fund Debut New Visual Identity

Retrieved on: 
Thursday, September 26, 2019
Biotechnology, Health, Philanthropy, Pharmaceutical, Oncology, Research, Foundation, Science, Boston Red Sox, The Jimmy Fund, Dana–Farber Cancer Institute, Health, Farber, Dàna, Medicine, Sidney Farber, Dana-Farber Cancer Institute, the Jimmy Fund

Dana-Farber Cancer Institute unveiled a new visual identity today, modernizing its logo and that of the Jimmy Fund with a vivid blue and gold palette.

Key Points: 
  • Dana-Farber Cancer Institute unveiled a new visual identity today, modernizing its logo and that of the Jimmy Fund with a vivid blue and gold palette.
  • The new Dana-Farber and Jimmy Fund logos celebrate our historic legacy, symbolize what we are today and point to our next chapter of discovery and hope.
  • The new Jimmy Fund logo utilizes the same new Dana-Farber color palette to emphasize the relationship between the fundraising arm and the Institute it supports.
  • It also refreshes the image of Jimmy, the boy who launched the Jimmy Fund in 1948.

Valvoline Instant Oil Change raises over $66,500 for cancer research and patient care at Dana-Farber Cancer Institute

Retrieved on: 
Tuesday, September 24, 2019
Cancer organizations, Health, Harvard Medical School, Boston Red Sox, The Jimmy Fund, Dana–Farber Cancer Institute, Medicine, Cancer research, Sidney Farber, BC Cancer Agency

The Jimmy Fund solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.

Key Points: 
  • The Jimmy Fund solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.
  • "Dana-Farber is one of the leading cancer institutes in the world, and the work they do to support cancer research and care is remarkable," said Don Smith, CEO of the Valvoline Instant Oil Change franchisee, Henley Enterprises.
  • Every dollar truly makes a huge impact on compassionate patient care and ground-breaking research being done at the institute."
  • The Jimmy Fund ( www.JimmyFund.org ) solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.

Valvoline Instant Oil Change supports cancer research and care at Dana-Farber Cancer Institute

Retrieved on: 
Thursday, August 1, 2019
Cancer organizations, Boston Red Sox, The Jimmy Fund, Health, Dana–Farber Cancer Institute, Medicine, Farber, Sidney Farber

"We are excited to participate in this program once again this year," said Don Smith, CEO of Henley Enterprises, Inc., the largest franchisee of Valvoline Instant Oil Change .

Key Points: 
  • "We are excited to participate in this program once again this year," said Don Smith, CEO of Henley Enterprises, Inc., the largest franchisee of Valvoline Instant Oil Change .
  • "The Jimmy Fund has long been a pillar in our community, and the work they do to support cancer research and care at Dana-Farber Cancer Institute is remarkable."
  • "We are proud to partner with Valvoline Instant Oil Change for their support in this fundraising program," said David Giagrando, Assistant Vice President, Corporate Partnerships, Dana-Farber Cancer Institute, Division of Development & the Jimmy Fund.
  • The Jimmy Fund ( www.JimmyFund.org ) solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.